Zobrazeno 1 - 8
of 8
pro vyhledávání: '"J T, Olin"'
Autor:
Wayne J. Morgan, Michael D. Cabana, Cori L. Daines, W. A. Gower, Wanda Phipatanakul, Rachel G. Robison, Stephen C. Lazarus, Harsha Vardhan Hampasandra Madan Kumar, Jyothi Marbin, Fernando D. Martinez, Hengameh H. Raissy, James N. Moy, Jonathan M. Gaffin, Michael E. Wechsler, Elliot Israel, Kristie R. Ross, Shannon Thyne, Ngoc P. Ly, Ross Myers, Susan J. Boehmer, R. F. Lemanske, Stephen P. Peters, Ian M. Paul, Kathryn V. Blake, Deborah A. Gentile, Michael O. Daines, Sachin N. Baxi, Fernando Holguin, John J. Lima, Avraham Beigelman, William J. Sheehan, C. A. Sorkness, J. T. Olin, Stanley J. Szefler, M. Benson, Leonard B. Bacharier, D. J. Jackson, Ronina A. Covar, Jason E. Lang, Anne M. Fitzpatrick, James F. Chmiel, Jacqueline A. Pongracic, David T. Mauger
Publikováno v:
The New England journal of medicine, vol 375, iss 7
BackgroundStudies have suggested an association between frequent acetaminophen use and asthma-related complications among children, leading some physicians to recommend that acetaminophen be avoided in children with asthma; however, appropriately des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aa9a79799ee7b40f329ac7c6203ca21
https://escholarship.org/uc/item/31v6d83t
https://escholarship.org/uc/item/31v6d83t
Autor:
Michael E Wechsler, J. T. Olin
Publikováno v:
BMJ (Clinical research ed.). 349
Asthma affects almost 20 million people in the United States and more than 300 million people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly available drugs. New drugs are needed because those that are currently avail
Publikováno v:
International journal of clinical practice. 65(4)
The cholinesterase inhibitor rivastigmine is available in both oral and transdermal forms. The efficacy of oral rivastigmine appears to be dose-dependent. The current analysis investigates the effect of dose on the efficacy of the rivastigmine transd
Publikováno v:
International journal of clinical practice. 64(2)
To compare the safety and tolerability of switching patients with mild-to-moderate Alzheimer's disease from donepezil to either rivastigmine capsule or transdermal patch.Three studies investigated the switch from donepezil to rivastigmine; study US13
Publikováno v:
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 9(4)
The authors performed a 6-week, randomized, double-blind, placebo-controlled, parallel-group trial of carbamazepine (400 mg/day) with 21 agitated subjects (16 completers) who had been treated unsuccessfully with antipsychotics. There was greater impr
Publikováno v:
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 7(4)
To examine whether informant-based assessments of patients with Alzheimer's disease (AD) can be used longitudinally to track patient functioning, the authors followed AD patients (N=153) and their caregivers over 1 year with the Relative's Assessment
Publikováno v:
International journal of geriatric psychiatry. 13(8)
Impairment in list learning is considered a primary symptom of Alzheimer's disease (AD), yet there are no published reports examining the relationship between list learning and severity of cognitive impairment. We gave nine-item and 16-item versions
Autor:
L S, Schneider, J T, Olin, R S, Doody, C M, Clark, J C, Morris, B, Reisberg, F A, Schmitt, M, Grundman, R G, Thomas, S H, Ferris
Publikováno v:
Alzheimer disease and associated disorders. 11
This article reports the development and psychometric properties of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC). At present, a number of unvalidated CGIC scales are used in clinical trials, with various